|Articles|April 3, 2007

PuriCore Establishes Endoscope Reprocessor Marketing Partnership

MALVERN, Pa. and STAFFORD, UK -- PuriCore, the life sciences company focused on the development and commercialisation of its novel, safe antimicrobial technology, announces that its Sterilox Endoscopy division has established a sales and marketing partnership with BHT Hygienetechnik GmbH, the award-winning manufacturer of endoscope reprocessors and channel checking systems.

This new partnership significantly enhances PuriCores product portfolio. The combination of award-winning technologies from Sterilox Endoscopy and BHT will deliver among the fastest and safest large pass through reprocessing systems in the UK. The deal ensures that PuriCore and BHT can respond to their clients need for high-quality infection control.

This deal follows last months announcement that PuriCore had signed an exclusive distribution agreement with Minntech Corporation, one of the worlds leading manufacturers of automated endoscope reprocessors.

PuriCore is pleased to announce another partnership with a world-class AER manufacturer, said Greg Bosch, chief executive officer of PuriCore. The integration of our technologies provides significant cost-saving benefits to our NHS customers and further strengthens our position as the UKs leading provider of endoscopy reprocessing systems.

"The joint effort allows BHT to expand its existing offerings in the UK market for high level disinfection solutions in the most sensitive field of reprocessing flexible endoscopes, said Dr. Annecke, CEO and managing director of BHT.

Source: PuriCore


Related to this article

Water  (Adobe Stock 456102510 by stockphoto-graf)
Understanding current water quality is a starting point for ST108 implementation. John Kimsey, vice president of processing optimization and customer success for STERIS, spoke about his HSPA presentation on assessing readiness, distinguishing system qualification from routine testing, and understanding where water samples should be collected.
AORN26 New Orleans 2026  (Adobe Stock)
Missing instruments and processing delays can strain OR–SPD relationships. At AORN 2026, John Kimsey, vice president of processing optimization and customer success for STERIS, discusses understanding root causes, exploring off-site reprocessing for ambulatory surgical centers, and using hands-on simulation to help surgical teams see sterile processing from a different perspective.